Drugs & pharma · US
3 stories in 24h · Health, Markets · Clear all filters
- The Mirror 'Sudden sight loss' risk alert to people taking Wegovy or Mounjaro
- The Mirror Grandad sues Ozempic maker Novo Nordisk claiming weight loss jab left him partially blind
-
Markets · China
South China Morning PostCNSource has a paywall
Eli Lilly beats Novo Nordisk to China approval for first oral GLP-1 weight-loss drugChina has approved US pharmaceutical giant Eli Lilly’s weight-loss pill orforglipron, making it the country’s first available oral…